Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2022

Month: November

Request Number: A-2020-001926

Request Summary: Adverse Drug Reactions (ADRs) for Rexulti. Report numbers: 921450, 922825, E2B_03409939, E2B_03416468. ADRs for Tolvaptan. Report numbers: E2B_03420920, E2B_03425375.

Disposition: Disclosed in part

Number of pages: 73

Date modified: